Complications and Litigation Associated With Injectable Facial Fillers: A Cross-Sectional Study

Soft-tissue injectable fillers are a popular treatment option for patients seeking minimally invasive facial rejuvenation. The use of soft-tissue fillers has increased significantly in the past 10  years. In 2017 alone, clinicians administered nearly 2.7 million soft-tissue fillers, up from 1.3 million in 2007. Although injectable fillers have a relatively high safety profile compared with more invasive rejuvenation procedures, serious adverse events, including intra-arterial injections, nec rosis, and visual symptoms such as blindness, have been documented.
Source: Journal of Oral and Maxillofacial Surgery - Category: ENT & OMF Authors: Tags: Craniomaxillofacial deformities/sleep disorders/cosmetic surgery Source Type: research